NIAGARA FALLS —
A few years back I wrote an article that questioned the effectiveness and potentially exposed some risks associated with the Swine flu vaccine.
I was slammed with both positive and negative emails. I am now about to raise some concerns about another vaccine in hopes of educating you, not causing anxiety.
For many young girls, and now boys, the American Medical Association and other medical organizations are recommending vaccination with the Gardisil (or similar) vaccine.
Gardasil is a vaccine that supposedly helps prevent 4 types of HPV (human papillomavirus), 2 of which have been linked to cervical cancer and 2 types that are associated with genital warts.
What most people do not know is that there are more than 100 various strains of HPV.
First I need to give you some information on HPV before I can argue my case against the Gardisil vaccine.
HPV is a very common virus that infects at least 50 percent of all sexually active people at some time during their lives. Many people do not even know that they have it, as many strains do not cause warts or cervical cancer. HPV infects men as well as women and 40 or more types are easily spread through sexual contact. The remaining types can be linked to warts on other areas of the body.
The majority of people I see who are positive for HPV do not have warts. Sexual transmission of HPV can be spread via the exchange of bodily fluids. Condoms do not insure protection.
The great news is that once you are diagnosed with HPV, chances are it will go away on its own over the years. I see many women who have had previously positive HPV results who later turn up negative. The key is to have yourself examined regularly. If you are sexually active with multiple partners you are likely to have the virus.
Now back to Gardisil. Remember, I said it only protects you against four strains of HPV and there are hundreds.
The incidence of cervical cancer is has been declining since long before the Gardisil vaccine was introduced. Pap smears have detected pre cancerous and even cancerous conditions of the cervix long before they become lethal and death rates are very low. According to data I have found up to 2007, the cervical cancer rate is 8.1 out of 100,000 women per year in the United States. Unfortunately, 2.4 women per 100,000 will die from it — that’s 0.000024 percent.
Now, lets look at the high percent of injected young girls who have had serious and even life-threatening side effects from the Gardisil vaccine.
According to the Vaccine Adverse Event Reporting System (medalerts.org), as of January 2010, there were more that 17,000 reports of adverse reactions to this vaccine and 59 deaths and 18 of these deaths were girls under 17. When you compare these numbers to women who are not vaccinated, it is absolutely safer to do nothing — just get your Pap smears!
These tragic numbers are associated to a vaccine that is not medically necessary. HPV can clear itself up over time with focus on improving your immune system. I intuitively wonder about those poor girls from downstate NY who are suffering from all those neurologic symptoms. I’d like to know when and where they got their vaccines and query the lot number.
For those of you who have daughters that have already received the vaccine, please don’t panic and do not be angry with your physician. Physicians and other healthcare providers are given very convincing statistics by the drug companies that manufacture the vaccine and a host of other drugs. I know from experience how this can sway my decision-making ability. Educate yourself and make the best decisions possible — that is all you can do.
If you only remember one thing, remember this: Cancer and many other diseases are not established in your body from lack of a pill or vaccine. How you eat, live and think makes you either an open door to disease or an unlikely candidate.
Catherine Stack is a doctor of naturopathy and a certified nurse midwife. Her practice is located at Journey II Health in Niagara Falls. She can be reached at 298-8603 or at her website at journeyiihealth.com.